Γεώργιος Παπαζήσης

Εικόνα Γεώργιος Παπαζήσης

Γνωστικό αντικείμενο: 

Φαρμακολογία-Κλινική Φαρμακολογία
Εκπαίδευση

Μετεκπαίδευση

Uppsala Monitoring Centre, WHO collaborating centre for international drug monitoring

Δημοσιεύσεις

Pubmed 58, citations 1450, h index 23

Διακρίσεις

Mentor for Scientists/PhD candiate, Technical University Munich, Department of Psychiatry. 

 

 

Σύντομο βιογραφικό: 

Dr. Georgios Papazisis is a Full Professor of Basic and Clinical Pharmacology at the Department of Clinical Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Greece. He is a specialized Psychiatrist and has also obtained the Greek Medical board certification of the medical sub-specialty of Clinical Pharmacology.  Currently, he is the Medical Director of the Clinical Research Unit of the School of Medicine, at the Papageorgiou Hospital in Thessaloniki, coordinating early phase clinical trials. Dr. Papazisis the Chairman of the Postgraduate Program ‘Vaccines and Infectious Diseases’ at the School of Medicine. He serves also as the Chair of the Committee for Bioethics and Medical Ethics of the School of Medicine. Recently he became member of the management Board of the Greek National Regulatory Organization for Medicines (ΕΟΦ) and is also member of the national experts committee of the Hellenic National Public Health Organization. Dr. Papazisis is the Greek delegate of the UEMS (Union Européenne des Médecins Spécialistes) section of Pharmacology, UEMS member of the i. newly established Federation for Medical Ethics and also the ii. thematic Federation for Equality, Diversity & Inclusivity. He is also the administrator for the Aristotle University Organization of the NIH US National Library of Medicine clinical trial registry ClinicalTrials.gov.
 
Clinical trials, pharmacovigilance (psychotropic drug safety, vaccine safety and patient safety), pharmacoepidemiology, immunopharmacology and neuropsychopharmacology are his fields of interest. In 2018 he completed the pharmacovigilance training course at the Uppsala Monitoring Centre, the WHO collaborating Centre for international drug monitoring. He is the pharmacovigilance referent person for the Greek National Hub in the  conect4children (c4c) project. Dr Papazisis served as Principal Investigator and sub-PI in several phase I, II and IV clinical trials and Horizon2020 programs. He is member of Vaccelerate, the pan-European backbone for the acceleration of phase 2 & 3 COVID-19 vaccine trials and member of the Council for International Organizations of Medical Sciences (CIOMS) Working Group (WG) XII on Benefit-Risk Balance for Medicinal Products. He is also member of the ‘Evidence Based Psychiatry’ section of the World Psychiatric Association
Dr. Papazisis has active international collaborations with several academic institutions worldwide (Technical University Munich, Germany; University of Maastricht, The Netherlands; Millennium Institute of Immunology and Immunotherapy, Pontificia Universidad Católica de Chile; University of Heartfordshire, UK; European University of Cyprus and Autonoma University Barcelona, Spain.)
Dr Papazisis has received several research, teaching and mentoring awards from the Aristotle University. His publication list includes over 100 PubMed papers, 4 book Chapters in international (Elsevier 2016, Springer 2017, Wiley 2023) and Greek books. His work has over 2800 citations with an h-index of 31(Google Scholar, ORCID).

Αναλυτικό βιογραφικό: 

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.